Leonardo DRS, Inc.
DRS
35.78
-1.00
-2.72%
Leonardo DRS, Inc.
US · DRS
#1485 by market cap
Listed 2021
35.78
-1.00
-2.72%
Live - 5344 symbols - heartbeat 407s ago
· 2026-10-08 05:47
Pre-market
35.91
+0.37%
After-hours
36.00
+0.61%
Overnight
35.78
0.00%
- Market cap
- 9.55B
- P/E (TTM)i
- 30.07
- P/Bi
- 3.41
- EPSi
- 1.03
- Div yieldi
- 1.01%
- 52W posi
- 19%
Reader sentiment
Are you bullish or bearish on DRS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.90, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +12.80% YoY
Margins
- Gross margin
- 23.82%
- Operating margin
- 9.54%
- Net margin
- 7.62%
Key ratios & quality
- Enterprise valuei
- 9.28B
- Altman Z-Scorei
- 3.90
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.33B | 2.71B | 2.78B | 2.88B | 2.69B | 2.83B | 3.23B | 3.65B |
| Gross profit | 414.00M | 459.00M | 494.00M | 547.00M | 575.00M | 648.00M | 736.00M | 869.00M |
| Selling & admin expenses | 268.00M | 277.00M | 283.00M | 293.00M | 357.00M | 384.00M | 414.00M | 497.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 45.00M | 163.00M | 181.00M | 236.00M | 561.00M | 231.00M | 293.00M | 348.00M |
| Pretax profit | -17.00M | 95.00M | 112.00M | 200.00M | 525.00M | 192.00M | 264.00M | 336.00M |
| Tax | -7.00M | 20.00M | 27.00M | 46.00M | 120.00M | 24.00M | 51.00M | 58.00M |
| Net profit | -10.00M | 75.00M | 85.00M | 154.00M | 405.00M | 168.00M | 213.00M | 278.00M |
| Basic EPS | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| Diluted EPS | -0.07 | 0.52 | 0.59 | 0.73 | 1.88 | 0.64 | 0.80 | 1.03 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 799.00M | 829.00M | 960.00M | 1.06B | 846.00M | 913.00M |
| Gross profit | 181.00M | 197.00M | 222.00M | 269.00M | 212.00M | 237.00M |
| Selling & admin expenses | 117.00M | 121.00M | 123.00M | 136.00M | 130.00M | 129.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 59.00M | 70.00M | 93.00M | 126.00M | 77.00M | 102.00M |
| Pretax profit | 58.00M | 67.00M | 87.00M | 124.00M | 77.00M | 100.00M |
| Tax | 8.00M | 13.00M | 15.00M | 22.00M | 15.00M | 14.00M |
| Net profit | 50.00M | 54.00M | 72.00M | 102.00M | 62.00M | 86.00M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.19 | 0.20 | 0.26 | 0.38 | 0.23 | 0.32 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | -- | 1.25B | 1.26B | 1.39B | 1.71B | 1.92B | 2.16B | 2.33B |
| Cash & ST investments | -- | 85.00M | 61.00M | 240.00M | 306.00M | 467.00M | 598.00M | 647.00M |
| Inventory | -- | 209.00M | 247.00M | 205.00M | 319.00M | 329.00M | 358.00M | 352.00M |
| Total assets | -- | 2.89B | 2.96B | 3.07B | 3.68B | 3.92B | 4.18B | 4.49B |
| Total current liabilities | -- | 1.00B | 975.00M | 989.00M | 1.04B | 1.08B | 1.12B | 1.23B |
| Short-term debt | -- | 77.00M | 75.00M | 65.00M | 54.00M | 80.00M | 52.00M | 54.00M |
| Long-term debt | -- | 656.00M | 374.00M | 352.00M | 365.00M | 349.00M | 340.00M | 321.00M |
| Total liabilities | -- | 1,869,000,000.00 | 1,529,000,000.00 | 1,476,000,000.00 | 1,550,000,000.00 | 1,596,000,000.00 | 1,627,000,000.00 | 1,756,000,000.00 |
| Total equity | -- | 1.02B | 1.43B | 1.59B | 2.13B | 2.33B | 2.56B | 2.73B |
| Retained earnings | -- | -3.22B | -3.14B | -2.98B | -2.97B | -2.81B | -2.59B | -2.32B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.07B | 2.03B | 2.17B | 2.33B | 2.06B | 2.04B |
| Cash & ST investments | 380.00M | 278.00M | 309.00M | 647.00M | 328.00M | 270.00M |
| Inventory | 385.00M | 400.00M | 404.00M | 352.00M | 371.00M | 383.00M |
| Total assets | 4.10B | 4.08B | 4.25B | 4.49B | 4.21B | 4.20B |
| Total current liabilities | 1.03B | 958.00M | 1.08B | 1.23B | 1.11B | 1.07B |
| Short-term debt | 54.00M | 49.00M | 52.00M | 54.00M | 40.00M | 40.00M |
| Long-term debt | 335.00M | 331.00M | 326.00M | 321.00M | 140.00M | -- |
| Total liabilities | 1,525,000,000.00 | 1,479,000,000.00 | 1,597,000,000.00 | 1,756,000,000.00 | 1,441,000,000.00 | 1,394,000,000.00 |
| Total equity | 2.57B | 2.60B | 2.65B | 2.73B | 2.77B | 2.80B |
| Retained earnings | -2.54B | -2.49B | -2.42B | -2.32B | -2.25B | -2.17B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 105.00M | 157.00M | 125.00M | 178.00M | 33.00M | 205.00M | 271.00M | 366.00M |
| Depreciation & amortization | 128.00M | 51.00M | 53.00M | 58.00M | 65.00M | 85.00M | 91.00M | 93.00M |
| Free cash flow | 65.00M | 102.00M | 69.00M | 118.00M | -32.00M | 145.00M | 186.00M | 227.00M |
| Dividends paid | -- | -- | 0 | 0 | -396.00M | 0 | 0 | -96.00M |
| Stock buybacks / issuance | -- | -- | -- | 0 | 0 | 12.00M | 16.00M | -26.00M |
| Ending cash balance | 79.00M | 85.00M | 61.00M | 240.00M | 306.00M | 467.00M | 598.00M | 647.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -138.00M | -28.00M | 107.00M | 425.00M | -66.00M | 35.00M |
| Depreciation & amortization | 23.00M | 23.00M | 23.00M | 24.00M | 24.00M | 26.00M |
| Free cash flow | -170.00M | -56.00M | 77.00M | 376.00M | -96.00M | 6.00M |
| Dividends paid | -24.00M | -24.00M | -24.00M | -24.00M | -24.00M | -24.00M |
| Stock buybacks / issuance | -3.00M | -8.00M | -4.00M | -11.00M | -1.00M | -10.00M |
| Ending cash balance | 380.00M | 278.00M | 309.00M | 647.00M | 328.00M | 270.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | 7.36 | 6.95 | 10.20 | 21.77 | 7.55 | 8.73 | 10.52 |
| ROA %i | -- | 2.60 | 2.91 | 5.11 | 12.01 | 4.42 | 5.26 | 6.41 |
| ROIC %i | -- | 6.86 | 7.04 | 8.96 | 18.36 | 7.34 | 7.88 | 9.16 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | 10.77 | 11.04 | 11.75 |
| EBIT margin %i | 1.76 | 5.90 | 6.34 | 8.16 | 20.76 | 8.07 | 8.81 | 9.43 |
| FCF / sales %i | 2.79 | 3.76 | 2.48 | 4.10 | -- | 5.13 | 5.75 | 6.22 |
| Current ratioi | -- | 1.25 | 1.30 | 1.40 | 1.64 | 1.78 | 1.94 | 1.89 |
| Quick ratioi | -- | 0.99 | 0.97 | 1.15 | 1.29 | 1.42 | 1.54 | 1.55 |
| Debt / assetsi | -- | 28.43 | 17.93 | 15.97 | 13.24 | 12.68 | 10.95 | 10.48 |
| LT debt / equityi | -- | 73.01 | 31.89 | 26.68 | 20.36 | 17.94 | 15.88 | 15.24 |
| Interest coveragei | 0.71 | 2.46 | 2.75 | 6.71 | 16.44 | 6.33 | 13.57 | 43.00 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 7.26 | -0.26 | 0.57 | 3.95 | 10.65 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | 75.44 | 25.50 | 11.42 | -11.79 |
| FCF CAGR (3Y) %i | -- | -- | -- | 21.99 | -- | 28.09 | 16.38 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 9.50 | 9.99 | 10.35 | 10.52 | 10.86 | 11.92 |
| ROA %i | 5.94 | 6.33 | 6.54 | 6.41 | 6.98 | 7.78 |
| ROIC %i | 8.46 | 8.74 | 9.05 | 9.16 | 9.75 | 10.49 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 9.03 | 9.27 | 9.36 | 9.43 | 9.80 | 10.43 |
| FCF / sales %i | 8.70 | 6.87 | 7.43 | 6.22 | 8.15 | 9.61 |
| Current ratioi | 2.02 | 2.11 | 2.00 | 1.89 | 1.86 | 1.92 |
| Quick ratioi | 1.57 | 1.63 | 1.56 | 1.55 | 1.47 | 1.49 |
| Debt / assetsi | 11.04 | 11.57 | 11.10 | 10.48 | 6.44 | 6.36 |
| LT debt / equityi | 15.48 | 16.27 | 15.82 | 15.24 | 8.34 | 8.10 |
| Interest coveragei | 17.76 | 26.42 | 30.36 | 43.00 | 51.71 | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Advanced Sensing and Computing (ASC) is the largest reported line at 64.29% of revenue, across 3 reported segments.
- Integrated Mission Systems (IMS) follows at 36.47%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Advanced Sensing and Computing (ASC)64.29%
Integrated Mission Systems (IMS)36.47%
Quote time 2026-10-08 05:47:49 · For reference only, not investment advice and not tailored to your situation.